| [1] |
Chen Q, Liu ZC, Chen LP, et al. An analysis of incidence and mortality of colorectal cancer in china, 2003~2007[J]. Zhongguo Zhong Liu, 2012, 21(3):179-82. [陈琼, 刘志才, 程兰平, 等. 20 03~2007年中国结直肠癌发病与死亡分析[J]. 中国肿瘤, 20 12, 21(3): 179-82.]
|
| [2] |
Garland CF, Garland FC. Do sunlight and vitamin D reduce the likelihood of colon cancer?[J]. Int J Epidemiol, 1980, 9(3): 227-31.
|
| [3] |
Evans SR, Shchepotin EI, Young H, et al. 1,25-dihydroxyvitamin D3 synthetic analogs inhibit spontaneous metastases in a 1, 2-dimethylhydrazine-induced colon carcinogenesis model[J]. Int J Oncol, 2000, 16(6):1249-54.
|
| [4] |
Newmark HL, Yang K, Kurihara N, et al. Western-style dietinduced colonic tumors and their modulation by calcium and vitamin D in C57Bl/6 mice: a preclinical model for human sporadic colon cancer[J]. Carcinogenesis, 2009, 30(1): 88-92.
|
| [5] |
Diaz GD, Paraskeva C, Thomas MG, et al. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy[J]. Cancer Res, 2000, 60(8): 2304-12.
|
| [6] |
Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement[J]. Int J Surg, 2010, 8(5): 336-41.
|
| [7] |
GA Wells, B Shea, D O’Connell, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in metaanalyses[ S] http://www.ohri.ca/programs/clinical_epidemiology/ oxford.asp. Accessed 30 April 2013.
|
| [8] |
Higgins JP, Thompson SG. Quantifying heterogeneity in a metaanalysis[ J] Stat Med, 2002, 21(11): 1539-58.
|
| [9] |
Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses[J]. BMJ, 2003, 327(7414): 557-60.
|
| [10] |
Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test[J]. BMJ, 1997, 315(7109): 629-34.
|
| [11] |
Neuhouser ML, Manson JE, Millen A, et al. The influence of health and lifestyle characteristics on the relation of serum 25 -hydroxyvitamin D with risk of colorectal and breast cancer in postmenopausal women[J]. Am J Epidemiol, 2012, 175(7): 673-84.
|
| [12] |
Lee JE, Li H, Chan AT, et al. Circulating levels of vitamin D and colon and rectal cancer: the Physicians’ Health Study and a metaanalysis of prospective studies[J]. Cancer Prev Res (Phila), 2011, 4( 5): 735-43.
|
| [13] |
Jenab M, Bueno-de-Mesquita HB, Ferrari P, et al. Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations: a nested casecontrol study[J]. BMJ, 2010, 340: b5500.
|
| [14] |
Wu K, Feskanich D, Fuchs CS, et al. A nested case-control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer[J]. J Natl Cancer Inst, 2007, 99(14): 1120-9.
|
| [15] |
Feskanich D, Ma J, Fuchs CS, et al. Plasma vitamin D metabolites and risk of colorectal cancer in women[J]. Cancer Epidemiol Biomarkers Prev, 2004, 13(9): 1502-8.
|
| [16] |
Otani T, Iwasaki M, Sasazuki S, et al. Plasma vitamin D and risk of colorectal cancer: the Japan Public Health Center-Based Prospective Study[J]. Br J Cancer, 2007, 97(3): 446-51.
|
| [17] |
Weinstein SJ, Yu K, Horst RL, et al. Serum 25-hydroxyvitamin D and risks of colon and rectal cancer in Finnish men[J]. Am J Epidemiol, 2011, 173(5): 499-508.
|
| [18] |
Woolcott CG, Wilkens LR, Nomura AM, et al. Plasma 25 -hydroxyvitamin D levels and the risk of colorectal cancer: The multiethnic cohort study[J]. Cancer Epidemiol Biomarkers Prev, 20 10, 19(1): 130-4.
|
| [19] |
Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomized double blind controlled trial[J]. BMJ, 2003, 326(7387): 469.
|
| [20] |
Giovannucci E. Epidemiology of vitamin D and colorectal cancer [J] Anticancer Agents Med Chem, 2013, 13(1): 11-9.
|
| [21] |
Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline[J]. J Clin Endocrinol Metab, 20 11, 96(7): 1911-30.
|
| [22] |
Slattery ML, Neuhausen SL, Hoffman M, et al. Dietary calcium, vitamin D, VDR genotypes and colorectal cancer[J]. Int J Cancer, 20 04, 111(5): 750-6.
|
| [23] |
Slattery ML, Wolff RK, Herrick JS, et al. Calcium, vitamin D, VDR genotypes,and epigenetic and genetic changes in rectal tumors[J]. Nutr Cancer, 2010, 62(4): 436-42.
|
| [24] |
Huncharek M, Muscat J, Kupelnick B. Colorectal cancer risk and dietary intake of calcium, vitamin D, and dairy products: a metaanalysis of 26,335 cases from 60 observational studies[J]. Nutr Cancer, 2009, 61(1): 47-69.
|
| [25] |
Hu ZY, Zhou YP, Li SW, et al. 1,25-digydroxyvitaminD3 enhanced killing effect of carboplatin on growth in lung cancer cell A549[J]. Zhong Liu Fang Zhi Yan Jiu, 2013, 40(2): 125-30. [胡志勇, 周逸 鹏, 黎书炜, 等. 1,25-二羟基维生素D3增强卡铂对人肺癌A549 细胞的杀伤效果[J]. 肿瘤防治研究, Zhong Liu Fang Zhi Yan Jiu, 20 13, 40(2): 125-30.]
|
下载:
